Natural solutions,supported by science.
Translating nature's best into science-backed actives for pharmaceutical, nutraceutical and food & beverage brands since 2009.
Independent, with
four decades
behind it.
Ennature Bio Pharma Limited became an independent company in September 2026, demerged from India Glycols Limited. Established in 2009, Ennature today operates across bio-pharma, nutraceuticals and biopolymers.
Its manufacturing heritage runs back to India Glycols, incorporated in 1983 and the first company in the world to commercialise ethylene oxide and glycols from renewable agricultural feedstocks rather than fossil sources. The same green-first thinking runs through everything we make.
Our values.
Excellence
Pharmaceutical-grade rigour in everything we make.
Collaboration
Long-term partnerships, not transactions.
Innovation
Patented platforms and continuous investment in R&D.
Care
For the plants, the planet and the people we serve.
Built for the most demanding partners.
Diverse Manufacturing
A wide range of extraction and conversion platforms under one roof, so we can match the right process to each pharmaceutical and nutraceutical active.
International Accreditations
WHO-GMP, ISO 9001 & 22000, EU-GMP with CEP, HACCP, Halal and Kosher, backed by a 21 CFR Part 11-compliant quality system.
Strong Quality Focus
Documented, audit-ready processes and full data integrity from raw material to finished active. Proof, not promises.
Green Innovation
Our own sugarcane-based green CO₂ and solvents, with recycling and zero-discharge processing built into every line.
Global Presence
Trusted by partners and customers across 30+ countries, with the regulatory dossiers to support each market.
From a small beginning to diversification and growth.
- SCF-CO₂ plant commissioned at Pharma City, Dehradun
- Strategic partnership for Astaxanthin manufacturing
- Thiocolchicoside API production initiated
- Formulation plant established
- Global leadership in Thiocolchicoside API by export volume
- US patent granted for single-phase Lutein Ester extraction from tagetes
- Nicotine API production plant commissioned
- Nicotine facility expansion
- Launched MAXICUMA® and the LIMAN™ technology platform
- Introduced SCEMOD™ technology
- EU-GMP sitewide audit and CEP certification achieved
- Launched Aspargize™, Gingeren™ and Berbisol™
- Achieved NSF GMP certification for the manufacturing facility
- Successfully completed US FDA audit
- EU-GMP certification granted following audit
Talk to our team.
Samples, specifications and dossiers.